NCT00540137View on ClinicalTrials.gov

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

21

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

HIV Infections

Interventions

DRUG

nevirapine

400mg once daily

DRUG

atazanavir/ritonavir

atazanavir 300 mg once daily ritonavir 100 mg once daily

Trial Locations (2)

Unknown

Heart of England NHS Foundation Trust, Birmingham

W2 1NY

St. Mary's Hospital, London

Sponsors

Collaborators (1)

Boehringer Ingelheim

All Listed Sponsors

collaborator

Boehringer Ingelheim

INDUSTRY

lead

Imperial College London

OTHER